Cilostazol attenuates on-treatment platelet reactivity in patients with CYP2C19 loss of function alleles receiving dual antiplatelet therapy: a genetic substudy of the CILON-T randomised controlled trial

Kyung Woo Park; Jin Joo Park; Seung-Pyo Lee; Il-Young Oh; Jung-Won Suh; Han-Mo Yang; Hae-Young Lee; Hyun-Jae Kang; Young-Suk Cho; Bon-Kwon Koo; Tae-Jin Youn; In-Ho Chae; Dong-Ju Choi; Byung-Hee Oh; Young-Bae Park; Hyo-Soo Kim

doi:10.1136/hrt.2010.216499

Citation Tools

Platelet function

Original article

Cilostazol attenuates on-treatment platelet reactivity in patients with CYP2C19 loss of function alleles receiving dual antiplatelet therapy: a genetic substudy of the CILON-T randomised controlled trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Cite this article as:: Park KW, Park JJ, Lee S, et al

Cilostazol attenuates on-treatment platelet reactivity in patients with CYP2C19 loss of function alleles receiving dual antiplatelet therapy: a genetic substudy of the CILON-T randomised controlled trial

Heart 2011;97:641-647.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password